IP Verse

Fc-Optimized Anti-Cd25 For Tumour Specific Cell Depletion - EP3596123

The patent EP3596123 was granted to Cancer Research Technology on Jan 10, 2024. The application was originally filed on Mar 13, 2018 under application number EP18711313A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3596123

CANCER RESEARCH TECHNOLOGY
Application Number
EP18711313A
Filing Date
Mar 13, 2018
Status
Granted And Under Opposition
Dec 8, 2023
Grant Date
Jan 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZEROct 4, 2024PFIZERADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2004045512
DESCRIPTIONWO2006108670
DESCRIPTIONWO2008002933
DESCRIPTIONWO2015173384
DESCRIPTIONWO2017174331
DESCRIPTIONWO9007861
DESCRIPTIONWO9311238
INTERNATIONAL-SEARCH-REPORTWO2005115451
INTERNATIONAL-SEARCH-REPORTWO2014145907
OPPOSITIONWO2005115451
OPPOSITIONWO2014145907
OPPOSITIONWO2017174331
OTHEREP3596123

Non-Patent Literature (NPL) Citations (83) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BIELEKOVA B, Neurotherapeutics, (20130000), vol. 10, no. 1, pages 55 - 67-
DESCRIPTION- BINDER M et al., Cancer Res, (20070000), vol. 67, no. 8, pages 3518 - 23-
DESCRIPTION- CLYNES et al., Proc Natl Acad Sci USA, (19980000), vol. 95, pages 652 - 6-
DESCRIPTION- COUPER K et al., J Immunol., (20070000), vol. 178, pages 4136 - 4146-
DESCRIPTION- DANTAL J et al., Transplantation, (19910000), vol. 52, pages 110 - 5-
DESCRIPTION- ELPEK et al., J Immunol., (20070000), vol. 178, no. 11, pages 6840 - 8-
DESCRIPTION- Epitope Mapping Protocols in Methods in Molecular Biology, (19960000), vol. 66-
DESCRIPTION- ESTEP P et al., Mabs, (20130000), vol. 5, no. 2, pages 270 - 8-
DESCRIPTION- FAN G et al., J Hematol Oncol, (20150000), vol. 8, page 130-
DESCRIPTION- FECCI P et al., Clin Cancer Res., (20060000), vol. 12, pages 4294 - 4305-
DESCRIPTION- FREEMAN, Proc Natl Acad Sci USA, (20080000), vol. 105, pages 10275 - 6-
DESCRIPTION- GOLGHER et al., Eur J Immunol., (20020000), vol. 32, no. 11, pages 3267 - 75-
DESCRIPTION- HALLETT W et al., Biol Blood Marrow Transplant, (20080000), vol. 14, pages 1088 - 1099-
DESCRIPTION- HAYES J et al., J Inflamm Res, (20160000), vol. 9, pages 209 - 219-
DESCRIPTION- HODI et al., Proc. Natl. Acad. Sci. USA, (20080000), vol. 105, pages 3005 - 3010-
DESCRIPTION- IDUSOGIE et al., J Immunol, (20010000), vol. 166, pages 2571 - 5-
DESCRIPTION- JONES et al., Cancer Immun., (20020000), vol. 22, no. 2, page 1-
DESCRIPTION- KABAT, J Biol Chem, (19770000), vol. 252, pages 6609 - 6616-
DESCRIPTION- KEARNS JD et al., Mol Cancer Ther., (20150000), vol. 14, pages 1625 - 36-
DESCRIPTION- KOHM A et al., J Immunol., (20060000), vol. 176, pages 3301 - 5-
DESCRIPTION- KUFER et al., Trends Biotechnol, (20040000), vol. 22, pages 238 - 44-
DESCRIPTION- LABRIJN AF et al., Nat Protoc., (20140000), vol. 9, pages 2450 - 63-
DESCRIPTION- LANGEDIJK JP et al., Analytical Biochemistry, (20110000), vol. 417, pages 149 - 155-
DESCRIPTION- LAZAR et al., Proc Natl Acad Sci USA, (20060000), vol. 103, pages 2005 - 2010-
DESCRIPTION- LOWENTHAL J.W et al., J. Immunol., (19850000), vol. 135, pages 3988 - 3994-
DESCRIPTION- MCNEILL A et al., Scand J Immunol, (20070000), vol. 65, pages 63 - 9-
DESCRIPTION- MCNEILL A et al., Scand J Immunol., (20070000), vol. 65, pages 63 - 9-
DESCRIPTION- MOREAU, J.-L et al., Eur. J. Immunol., (19870000), vol. 17, pages 929 - 935-
DESCRIPTION- NIMMERJAHN F et al., Science, (20050000), vol. 310, pages 1510 - 2-
DESCRIPTION- ONISHI H et al., Anticanc. Res., (20120000), vol. 32, pages 997 - 1003-
DESCRIPTION- ONIZUKA et al., Cancer Res., (19990000), vol. 59, no. 13, pages 3128 - 33-
DESCRIPTION- ONIZUKA S et al., Canc Res., (19990000), vol. 59, pages 3128 - 3133-
DESCRIPTION- QUEEN C et al., PNAS, (19890000), vol. 86, no. 24, pages 10029 - 10033-
DESCRIPTION- QUEZADA et al., J Clin Invest., (20060000), vol. 116, no. 7, pages 1935 - 45-
DESCRIPTION- RICHARDS et al., Mol Cancer Ther, (20080000), vol. 7, pages 2517 - 27-
DESCRIPTION- ROGHANIAN A et al., Cancer Cell, (20150000), vol. 27, pages 473 - 488-
DESCRIPTION- ROZAN C et al., Mol Cancer Ther., (20130000), vol. 12, pages 1481 - 91-
DESCRIPTION- RUBIN et al., Hybridoma, (19850000), vol. 4, no. 2, pages 91 - 102-
DESCRIPTION- SETIADY Y et al., Eur J Immunol., (20100000), vol. 40, pages 780 - 6-
DESCRIPTION- SETIADY Y et al., Eur. J. Immunol., (20100000), vol. 40, pages 780 - 6-
DESCRIPTION- SHANG B et al., Sci Rep., (20150000), vol. 5, page 15179-
DESCRIPTION- SHIMIZU et al., J Immunol., (19990000), vol. 163, no. 10, pages 5211 - 8-
DESCRIPTION- SIMPSON et al., J Exp Med, (20130000), vol. 210, pages 1695 - 710-
DESCRIPTION- SKERRA, FEBS J, (20080000), vol. 275, pages 2677 - 83-
DESCRIPTION- SLIWKOWSKI; MELLMAN, Science, (20130000), vol. 341, pages 192 - 8-
DESCRIPTION- SMITH et al., Proc Natl 25 Acad Sci USA, (20120000), vol. 109, pages 6181 - 6-
DESCRIPTION- SMYTH M et al., Immunol Cell Biol., (20140000), vol. 92, pages 473 - 4-
DESCRIPTION- SPEISS C et al., Molecular Immunology, (20150000), vol. 67, pages 95 - 106-
DESCRIPTION- TANAKA et al., Microbiol. Immunol, (19860000), vol. 30, no. 4, pages 373 - 388-
DESCRIPTION- TEEGE S et al., Sci Rep, (20150000), vol. 5, page 8959-
DESCRIPTION- TILLER K; TESSIER P, Annu Rev Biomed Eng., (20150000), vol. 17, pages 191 - 216-
DESCRIPTION- TIMMERMANN P et al., J. Mol. Recognit., (20070000), vol. 20, pages 283 - 99-
DESCRIPTION- "Uniprot", Database accession no. P01589-
DESCRIPTION- "Uniprot", Database accession no. P01590-
DESCRIPTION- VARGAS A et al., Immunity, (20170000), vol. 48, no. 6, pages 577 - 586-
DESCRIPTION- VOLK HD et al., Clin. exp. Immunol., (19890000), vol. 76, pages 121 - 5-
DESCRIPTION- WEBER, J Nucl Med, (20090000), vol. 50, pages 15 - 105-
DESCRIPTION- WEINER G, Nat Rev Cancer, (20150000), vol. 15, pages 361 - 370-
DESCRIPTION- ZHANG et al., Cancer Biother Radiopharm, (20090000), vol. 24, no. 3, pages 303 - 309-
EXAMINATION- PHILLIPS K E ET AL, "IL-2Ralpha-directed Monoclonal Antibodies Provide Effective Therapy in a Murine Model of Adult T-Cell Leukemia by a Mechanism other than Blockade of IL-2/IL-2Ralpha Interaction", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20001215), vol. 60, ISSN 0008-5472, pages 6977 - 6984, XP002978176-
EXAMINATION- BERKOWITZ JONATHAN L. ET AL, "Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma", CLINICAL IMMUNOLOGY, AMSTERDAM, NL, (20141201), vol. 155, no. 2, doi:10.1016/j.clim.2014.09.012, ISSN 1521-6616, pages 176 - 187, XP055895294
EXAMINATION- Kuhn Deborah ET AL, "The role of interleukin-2 receptor alpha in cancer", FRONTIERS IN BIOSCIENCE, US, (20050301), vol. 10, no. 1-3, doi:10.2741/1631, ISSN 1093-9946, pages 1462 - 1474, XP055895427
EXAMINATION- KOHM ADAM P. ET AL, "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4 + CD25 + T Regulatory Cells", THE JOURNAL OF IMMUNOLOGY, US, (20060303), vol. 176, no. 6, doi:10.4049/jimmunol.176.6.3301, ISSN 0022-1767, pages 3301 - 3305, XP055901432
INTERNATIONAL-SEARCH-REPORT- JOHN H. SAMPSON ET AL, "A Pilot Study of IL-2R[alpha] Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma", PLOS ONE, (20120227), vol. 7, no. 2, doi:10.1371/journal.pone.0031046, page e31046, XP055476722 [X] 1-19,38 * See Figure 6 * [I] 20-37,39-63
INTERNATIONAL-SEARCH-REPORT- NICOLAS GOUDIN ET AL, "Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells", PLOS ONE, (20160624), vol. 11, no. 6, doi:10.1371/journal.pone.0157822, page e0157822, XP055393805 [A] 1-63 * the whole document *
OPPOSITION- Flaherty Dennis K, "Chapter 23 - Cytokines and Biologic Modifiers", Immunology for pharmacy, US, Elsevier, (20110818), pages 181 - 188, ISBN 978-0-323-06947-2, XP093232301-
OPPOSITION- Kathleen E. Phillips; Bert Herring; Latresia A. Wilson; Marc S. Rickford; Meili Zhang; Carolyn K. Goldman; J. Yun Tso; Thomas A. Waldmann, "IL-2Rα-Directed Monoclonal Antibodies Provide Effective Therapy in a Murine Model of Adult T-Cell Leukemia by a Mechanism other than Blockade of IL-2/IL-2Rα Interaction", Cancer research, American Association for Cancer Research, San Diego, CA . Philadelphia (PA, San Diego, CA . Philadelphia (PA, (20001215), vol. 60, no. 24, ISSN 0008-5472, pages 6977 - 6984, XP002978176-
OPPOSITION- Shozaburo Onizuka; Isao Tawara; Jun Shimizu; Shimon Sakaguchi; Teizo Fujita; Eiichi Nakayama, "Tumor Rejection by in Vivo Administration of Anti-CD25 (Interleukin-2 Receptor α) Monoclonal Antibody", Cancer research, American Association for Cancer Research, San Diego, CA . Philadelphia (PA, San Diego, CA . Philadelphia (PA, (19990701), vol. 59, no. 13, ISSN 0008-5472, pages 3128 - 3133, XP002255931-
OPPOSITION- Kobayashi Hisataka, Tagaya Yutaka, Han Eui-Sik, Kim In-Sook, Le Nhat, Paik Chang H, Pastan Ira, Nelson David L, Waldmann Thomas A, Carrasquillo Jorge A, "USE OF AN ANTIBODY AGAINST THE SOLUBLE INTERLEUKIN 2 RECEPTOR α SUBUNIT CAN MODULATE THE STABILITY AND BIODISTRIBUTION OF INTERLEUKIN-2", Cytokine, ACADEMIC PRESS LTD, PHILADELPHIA, PA, US, US , (19991201), vol. 11, no. 12, doi:10.1006/cyto.1999.0509, ISSN 1043-4666, pages 1065 - 1075, XP093232292
OPPOSITION- Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon, Kroopa Joshi, Leila Mekkaoui, Marta H. Lesko, Enrique Miranda Rota, Rony Dahan, Andrew Georgiou, Anna Sledzinska, Assma Ben Aissa, Dafne Franz, Mariana Werner Sunderland, Yien Ning Sophia Wong, Jake Y. Henry, Tim O’brien, David Nicol, Ben Challacombe, Stephen A. Beers, Samra Turajlic, Martin Gore, James Larkin, Charles Swanton, Kerry A. Chester, Martin Pule, Jeffrey V. Ravetch, Teresa Marafioti, Karl S. Peggs, Sergio A. Quezada, Lavinia Spain, Andrew Wotherspoon, Nicholas Francis, Myles Smith, Dirk Strauss, Andrew Hayes, Aspasia Soultati, Mark Stares, Joanna Lynch, Nicos Fotiadis, Archana Fernando, Steve Hazell, Ashish Chandra, Lisa Pickering, Sarah Rudman, Simon Chowdhury, Mariam Jamal-Hanjani, Selvaraju Veeriah, Seema Shafi, Justyna Czyzewska-Khan, Diana Johnson, Joanne Laycock, Leticia Bosshard-Carter, Gerald Goh, Rachel Rosenthal, Pat Gorman, Nirupa Murugaesu, Robert E. Hynds, Gareth Wilson, Nicolai J. Birkbak, Tho, "Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors", Immunity, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20170401), vol. 46, no. 4, doi:10.1016/j.immuni.2017.03.013, ISSN 1074-7613, pages 577 - 586, XP055487134
OPPOSITION- CLYNES RAPHAEL A ET AL, "Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets", Nature Medicine, Nature Publishing Group US, New York, New York, (20000401), vol. 6, no. 4, doi:10.1038/74704, ISSN 1078-8956, pages 443 - 446, XP002291039
OPPOSITION- ADAMS GREGORY P, WEINER LOUIS M, "Monoclonal antibody therapy of cancer", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20050901), vol. 23, no. 9, doi:10.1038/nbt1137, ISSN 1087-0156, pages 1147 - 1157, XP002456710
OPPOSITION- Morris John C., Waldmann Thomas A., Janik John E., "Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas", Journal of Immunotoxicology, Taylor and Francis Group, US, US , (20080401), vol. 5, no. 2, doi:10.1080/15476910802129661, ISSN 1547-691X, pages 235 - 248, XP093232284
OPPOSITION- Zhang Meili, Yao Zhengsheng, Garmestani Kayhan, Yu Sarah, Goldman Carolyn K., Paik Chang H., Brechbiel Martin W., Carrasquillo Jorge A., Waldmann Thomas A., "Preclinical Evaluation of an Anti-CD25 Monoclonal Antibody, 7G7/B6, Armed with the β-Emitter, Yttrium-90, as a Radioimmunotherapeutic Agent for Treating Lymphoma", Cancer Biotherapy & Radiopharmaceuticals, Mary Ann Liebert., US, US , (20090601), vol. 24, no. 3, doi:10.1089/cbr.2008.0577, ISSN 1084-9785, pages 303 - 309, XP093232295
OPPOSITION- Michael J. Flynn; John A. Hartley, "The emerging role of anti‐CD25 directed therapies as both immune modulators and targeted agents in cancer", British Journal of Haematology, John Wiley, Hoboken, USA, Hoboken, USA, (20170530), vol. 179, no. 1, doi:10.1111/bjh.14770, ISSN 0007-1048, pages 20 - 35, XP071122009
OPPOSITION- Marie-Denise Poirier, Haban Houda, El Andaloussi Abdeljabar, "A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma", JOURNAL OF ONCOLOGY, Hindawi Publishing Corporation, US, US , (20090101), vol. 2009, doi:10.1155/2009/963037, ISSN 1687-8450, page 963037, XP055741895
OPPOSITION- Meili Zhang, Zhuo Zhang, Kayhan Garmestani, Carolyn K. Goldman, Jeffrey V. Ravetch, Martin W. Brechbiel, Jorge A. Carrasquillo, Thomas A. Waldmann, "Activating Fc Receptors Are Required for Antitumor Efficacy of the Antibodies Directed toward CD25 in a Murine Model of Adult T-Cell Leukemia", Cancer research, American Association for Cancer Research, San Diego, CA . Philadelphia (PA, San Diego, CA . Philadelphia (PA, (20040815), vol. 64, no. 16, doi:10.1158/0008-5472.CAN-04-1088, ISSN 0008-5472, pages 5825 - 5829, XP055718090
OPPOSITION- Kretschmer Anna, Schwanbeck Ralf, Valerius Thomas, Rösner Thies, "Antibody Isotypes for Tumor Immunotherapy", Transfusion Medicine Hemotherapy, KARGER, BASEL, CH, CH , (20170101), vol. 44, no. 5, doi:10.1159/000479240, ISSN 1660-3796, pages 320 - 326, XP055894976
OPPOSITION- John H. Sampson, Robert J. Schmittling, Gary E. Archer, Kendra L. Congdon, Smita K. Nair, Elizabeth A. Reap, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, James E. Herndon, April Coan, Roger E. Mclendon, David A. Reardon, James J. Vredenburgh, Darell D. Bigner, Duane A. Mitchell, "A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma", PLoS ONE, vol. 7, no. 2, doi:10.1371/journal.pone.0031046, page e31046, XP055476722
OPPOSITION- Nicolas Goudin, Pascal Chappert, Jérome Mégret, David-Alexandre Gross, Benedita Rocha, Orly Azogui, "Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells", PLOS ONE, vol. 11, no. 6, doi:10.1371/journal.pone.0157822, page e0157822, XP055393805
OPPOSITION- Kuhn Deborah, J., Dou Q Ping, "The role of interleukin-2 receptor alpha in cancer", FRONTIERS IN BIOSCIENCE, FRONTIERS IN BIOSCIENCE, ALBERTSON, NY, US, US , (20050301), vol. 10, no. 1-3, doi:10.2741/1631, ISSN 1093-9946, pages 1462 - 1474, XP055895427
OPPOSITION- Ortega G, Robb R J, Shevach E M, Malek T R, "The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.", Journal of Immunology, Williams & Wilkins Co., (19841001), vol. 133, no. 4, doi:10.4049/jimmunol.133.4.1970, ISSN 0022-1767, pages 1970 - 1975, XP093232309
OPPOSITION- Kohm Adam P., Mcmahon Jeffrey S., Podojil Joseph R., Begolka Wendy Smith, Degutes Mathew, Kasprowicz Deborah J., Ziegler Steven F., Miller Stephen D., "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4 + CD25 + T Regulatory Cells", Journal of Immunology, Williams & Wilkins Co., (20060315), vol. 176, no. 6, doi:10.4049/jimmunol.176.6.3301, ISSN 0022-1767, pages 3301 - 3305, XP055901432

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents